Effects of gut microbiota and their metabolites on benign diseases of the female reproductive system: A Mendelian randomization study
Placenta and Reproductive Medicine · 31.03.2026 · 5 (1) · 36-50
DOI: 10.54844/prm.2026.1178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta and Reproductive Medicine, online erschienen am 31.03.2026. Verfasst von Fangfang Dai und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Alterations in gut microbiota, including the composition of the flora, the abundance of specific species, and bacterial metabolites are related to the pathogenesis of benign diseases of the female reproductive system. Because of potential biases, such as confounding or reverse causation, the causal relationship between diseases of the female reproductive system and alterations in gut microbiota remains unclear. We applied two-sample Mendelian randomization (MR) to investigate the effect of alterations in gut microbiota on 18 benign diseases of the female reproductive system.
Methods
Instrumental variables for different classification levels of the gut microbiota including phylum, class, order, family, and genus, and several bacterial metabolites were selected. MR analysis was performed using inverse-variance weighted (IVW), MR-Egger, weighted median, MR-Robust Adjusted Profile Scoring (MR-RAPS), and MR pleiotropy residual sum and outlier tests. Cochran's IVW Q statistics were used to detect any potential heterogeneity.
Results
Notably, 49 genera of the gut microbiota exhibited a causal relationship with the benign diseases of the female reproductive system, with more than half of the genera exhibiting a role in two or more diseases. Six metabolites of the gut microbiota can be considered as indicators to detect the presence of the disease.
Conclusions
Alterations in a total of four phyla, five classes, four orders, ten families, and 49 genera of gut microbiota and six kinds of bacterial metabolites exhibited positive or negative effects on the female reproductive system. Our findings provide insights into potential novel biomarkers and therapy targets for many disease of the female reproductive system.
Zitieren
APA
Dai, F., & Sagnelli, M. P. (2026). Effects of gut microbiota and their metabolites on benign diseases of the female reproductive system: A Mendelian randomization study. Placenta and Reproductive Medicine, 5(1), 36-50. https://doi.org/10.54844/prm.2026.1178
Vancouver
Dai F, Sagnelli MP. Effects of gut microbiota and their metabolites on benign diseases of the female reproductive system: A Mendelian randomization study. Placenta and Reproductive Medicine. 2026;5(1):36-50. doi:10.54844/prm.2026.1178
BibTeX
@article{Dai2026,
author = {Dai, Fangfang and Sagnelli, Matthew Philip},
title = {Effects of gut microbiota and their metabolites on benign diseases of the female reproductive system: A Mendelian randomization study},
journal = {Placenta and Reproductive Medicine},
year = {2026},
volume = {5},
number = {1},
pages = {36--50},
doi = {10.54844/prm.2026.1178}
}
EUVIMED